Arasens Trial News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Arasens trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Arasens Trial Today - Breaking & Trending Today

Analysis Helps Distinguish the Molecular Profile of Intraductal Carcinoma of the Prostate

Benjamin Miron, MD, explains the purpose of studying the molecular profile of intraductal carcinoma of the prostate, expands on the potential prognostic and targetable alterations identified in patients with this histology, and discusses the planned cohort expansion and analysis of RNA signatures in this population. ....

United States , Fox Chase Cancer Center , Benjamin Miron , Caris Life Sciences , World Health Organization , Arasens Trial , Psa Response , Survival Outcomes , Intraductal Carcinoma Of The Prostate , Molecular Analysis , Asco 2023 ,

Link Between PSA Response and Survival Outcomes Supports Use of Darolutamide Plus ADT/Docetaxel as a SOC in mHSPC

Fred Saad, MD, FRCS, expands on the relationship between PSA responses and survival outcomes in the ARASENS trial, explained the use of 0.2 ng/mL as a standard cut off for undetectable PSA within this exploratory analysis, and discussed how this study elucidates future directions for research with triplet regimens in mHSPC. ....

United States , Fred Saad , Raymond Garneau , Montreal Cancer Institute , University Of Montreal Hospital Center , American Urological Association , University Of Montreal , Research Center , Department Of Surgery , Urological Association , Annual Meeting , Montreal Hospital Center , Montreal Cancer , Raymond Garneau Chair , Prostate Cancer , Arasens Trial , Psa Response , Survival Outcomes , Metastatic Hormone Sensitive Prostate Cancer , Triplet Regimens , Aua Meeting ,

Metastatic Hormone-Sensitive Prostate Cancer: Data From ARASENS and ARANOTE

A panel of medical oncologist reflect on clinical data from the ARASENS and ARANOTE trials utilizing combination strategies with darolutamide in mHSPC. ....

Key Updates , Metastatic Prostate Cancer Treatment , Hormone Sensitive Prostate Cancer , Data From , Prostate Cancer , Metastatic Hormone Sensitive Prostate Cancer , Arasens Trial , Arasens Study , Androgen Deprivation Therapy , Triplet Therapy , Triple Therapy , Combination Therapy , Aranote Trial , Aranote Study , Novel Therapy ,